Supply problems and insurance complications have made it difficult for people to start — and stay on — Wegovy and similar medications that are transforming obesity treatment, according to doctors and patients around the U.S.
Source: ctv business
Supply problems and insurance issues make popular weight-loss drugs hard to get in the U.S.

